首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of clinical tuberculosis and other mycobacterial diseases

缩写:

ISSN:2405-5794

e-ISSN:2405-5794

IF/分区:2.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引553
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Majdouline El Moussaoui,Nicolas Lambert,Patrick Massage et al. Majdouline El Moussaoui et al.
Misdiagnosis of Mycobacterium heraklionense tenosynovitis is common due to the challenging identification and perceived rarity of the disease. This can result in delayed therapy initiation and potentially irreversible consequences. In this ...
Xingxing Jin,Qianfang Hu,Yishi Li et al. Xingxing Jin et al.
Background/purpose: Tuberculosis remains a leading cause of infectious death worldwide, The potential for nucleic acid residue on bronchoscopes to cause false positive results in molecular diagnostic methods and subsequen...
Mohammad Yazdanmanesh,Keyvan Tadayon,Darya Bagherian Koshkghazi et al. Mohammad Yazdanmanesh et al.
Non-tuberculous mycobacteria (NTM) are among the most important pathogens in wild, captive, marine, and freshwater fish species. So, it is important to consider fish as the primary source of infection for aquarium fish and humans. The prese...
Samuel Engoru,Francis Bajunirwe,Jonathan Izudi Samuel Engoru
Rationale: Multi-drug-resistant tuberculosis (MDR-TB) poses a significant public health challenge to the control and successful eradication of TB globally. Suboptimal treatment outcomes are common among persons with MDR-T...
Rachel Marusinec,Tessa Clifton,Amit S Chitnis et al. Rachel Marusinec et al.
Background: Advanced pulmonary tuberculosis (APT) may reflect delays in tuberculosis (TB) diagnosis and contribute to ongoing disease transmission and poor outcomes. We characterized trends and factors associated with APT...
Albert Okumu,James Orwa,Ruth Sitati et al. Albert Okumu et al.
Multidrug-resistant tuberculosis (MDR-TB) is caused by M. tuberculosis (Mtb) with resistance to the first-line anti-TB medicines isoniazid (INH) and rifampicin (RIF). In Western Kenya, there is reported low prevalence of drug resistant stra...
Tanner M Johnson,Christina G Rivera,Grace Lee et al. Tanner M Johnson et al.
Mycobacterium tuberculosis (TB) remains the leading cause of infection-related mortality worldwide. Drug resistance, need for multiple antimycobacterial agents, prolonged treatment courses, and medication-related side effects are complicati...
Bernardo Castro-Rodriguez,Greta Franco-Sotomayor,Solón Alberto Orlando et al. Bernardo Castro-Rodriguez et al.
Tuberculosis (TB) is one of the three leading causes of death from a single infectious agent, Mycobacterium tuberculosis (MTB), together with COVID-19 and HIV/AIDS. This disease places a heavy burden on countries with low socio-economic dev...
Aneesha Raj,Nabiha S Khakoo,Alex A Ashkin et al. Aneesha Raj et al.
Objectives: To determine if integrating VDOT into TB therapy demonstrated non-inferiority to direct observation, and if VDOT utilization increased across Florida after the onset of Covid-19. ...
Soroush Borji,Sara Kooti,Rashid Ramazanzadeh et al. Soroush Borji et al.
Tuberculosis (TB) is a chronic infectious disease with multiple manifestations and gradual progression that remains a major health problem and a leading cause of death worldwide. In recent years, a number of DNA fingerprinting techniques ha...